Le défi du traitement de l'hypertension chez les diabétiques de type 2.

Norman M Kaplan

Le défi du traitement de l'hypertension chez les diabétiques de type 2.

Translated title of the contribution: The challenge to treat hypertensive patients with type 2 diabetes

Norman M Kaplan

Research output: Contribution to journal › Article › peer-review

Abstract

A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.

Translated title of the contribution	The challenge to treat hypertensive patients with type 2 diabetes
Original language	French
Pages (from-to)	S25-26
Journal	Presse médicale (Paris, France : 1983)
Volume	31 Spec No 2
State	Published - Oct 2002

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{15ba1d12615b4f26a31b7f27c665fa0c,

title = "Le d{\'e}fi du traitement de l'hypertension chez les diab{\'e}tiques de type 2.",

abstract = "A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.",

author = "Kaplan, {Norman M}",

year = "2002",

month = oct,

language = "French",

volume = "31 Spec No 2",

pages = "S25--26",

journal = "Nouvelle Presse Medicale",

issn = "0755-4982",

publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Le défi du traitement de l'hypertension chez les diabétiques de type 2.

AU - Kaplan, Norman M

PY - 2002/10

Y1 - 2002/10

N2 - A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.

AB - A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.

UR - http://www.scopus.com/inward/record.url?scp=0036780713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036780713&partnerID=8YFLogxK

M3 - Article

C2 - 12356002

AN - SCOPUS:0036780713

VL - 31 Spec No 2

SP - S25-26

JO - Nouvelle Presse Medicale

JF - Nouvelle Presse Medicale

SN - 0755-4982

ER -

Le défi du traitement de l'hypertension chez les diabétiques de type 2.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this